DRUG · Unmapped registry intervention
Atevirdine mesylate
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
NCT00000753
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Zidovudine
Normalized identity: zidovudineView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Zalcitabine
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Didanosine
Normalized identity: didanosineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIV Infectionsunresolved
Interventions
ZidovudineDRUG · verified · RxNorm: zidovudine
ZalcitabineDRUG
DidanosineDRUG · verified · RxNorm: didanosine
Sponsors & collaborators
Upjohncollaborator
Glaxo Wellcomecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00000753 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.